Biondi, Mia J
$200,000.00 CAD
- Department
- Canadian Institutes of Health Research
- Program
- Research in Priority Areas
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- March 1, 2022 – February 29, 2024
- Reference
- cihr-irsc:236-2021-2022-Q4-00227
Published purpose
• The CIHR HIV/AIDS Research Initiative (RI), under the leadership of the CIHR Institute of Infection and Immunity (III), is responsible for the funding, management and oversight of research with a primary focus on HIV/AIDS and/or other STBBI (as identified in the Public Health Agency of Canada’s pan-Canadian STBBI framework for action). This includes, but is not limited to: human immunodeficiency virus (HIV), hepatitis B (HBV) and C (HCV), chlamydia, gonorrhea, syphilis, and human papilloma virus (HPV). This funding is provided across all CIHR Research Themes: biomedical research, clinical research, health services research and social, cultural, environmental and population health research. • Research that focuses on key populations identified by Canada’s pan-Canadian STBBI framework for action is highly encouraged. • This priority announcement will fund one (1) early career investigator for a total of three (3) years
Community tags
Tags are applied by readers, not by this site. One tag per person per record.